Attachment L-9 Benefit Design Document_TPharm5.xlsx
XLSX spreadsheet 78 KB Posted
- Attached to
- DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) Federal contract opportunity
- Solicitation number
- HT940220R0002
- Issued by
- Defense Health Agency
About this file
This draft request for proposal and related documents outline requirements for pharmacy benefit management services under the Defense Health Agency's TRICARE Pharmacy Program, 5th Generation contract (TPharm5). The potential single-award contract would have an 18-month transition period and up to 9 years of total performance, including a phase-out period. Services include retail pharmacy network management, mail order pharmacy, specialty pharmacy, and coordination of clinical services. The draft RFP includes statements of objectives, quality standards, and descriptions of requirements for formulary management, claims processing, and patient safety reporting. Industry feedback is requested on contract structure and requirements by January 17, 2020. The Defense Health Agency intends to issue a formal solicitation in mid-2020 and hold an informational session on December 11, 2019 to discuss the draft.
View the file
Other files for this federal contract opportunity
Show all 50
DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) has more files on GovTribe.
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Pharmacy Cost Shares
| DoD Pharmacy Benefit Design Document |
| Current as of <DATE> |
| TRICARE Pharmacy (TPharm) Copayments/Cost-Shares in the United States (U.S.) (including Puerto Rico, Guam, the U.S. Virgin Islands, American Samoa, and the Northern Marianna Islands) |
| [NOTE: Unless otherwise indicated, the information below applies to all POS: Retail, Mail, and MHS Genesis] |
| Benefit Area | PLACE OF SERVICE | FORMULARY | NON-FORMULARY | ||
| Generic (Tier 1) | Brand Name | ||||
| (Tier 2)5 | (Tier 3) 1 | ||||
| COPAYMENT(S) |
1. Tricare Reimbursement Manual, Chapter 2, Addendum A –Pharmacy Payment Matrix.
2. Tricare Reimbursement Manual, Chapter 4, Section 3, § 5 – Tricare Deductible in Double Coverage
Military Treatment Facility (MTF) $0 $0 Not Applicable 2
Mail Order 4,7,8 $X $XX $XX 3
Retail Network Pharmacy 4,6,8 $XX $XX $XX 3
| Retail Non-Network Pharmacy (up to 30-day supply) | TRICARE Prime options: 50% copayment applies after point-of-service (POS) deductible is met | TRICARE Prime options: 50% copayment applies after POS deductible is met |
| All other beneficiaries: $XX or 20% of the total cost, whichever is greater, after annual deductible is met | All other beneficiaries: $XX or 20% of the total cost, whichever is greater, after annual deductible is met | |
| 1. Approval is required for active duty service members (ADSMs) at mail and retail. Non-formulary drugs may be obtained free of charge by ADSMs only if medical necessity has been established. All other beneficiaries will pay the copayments listed above. Medical necessity information should be submitted along with the prescriptions. The Department of Defense Pharmacy and Therapeutics Committee may set quantity limits on some medications. For more information, visit http://www.tricare.mil/CoveredServices/Pharmacy/Drugs/QuantityLimits |
2. Non-formulary drugs are generally not available at MTFs.
3. The non-formulary copayment applies unless medical necessity is established. An established medical necessity will allow a formulary copay.
4. Selected Vaccines in retail and OTC drugs in both retail and mail may be cost shared ($0 copay for vaccines; generic copay for covered OTC’s except Plan B One Step OTC - $0) when designated by the Assistant Secretary of Defense, Health Affairs
5. Compounded medications will have a cost share equal to or not less than the prevailing Formulary brand name cost share
6. For member submitted claims for prescriptions filled at a network pharmacy, allowable charges, member cost shares and reimbursement will be based on network pharmacy rates.
7. Selected prescription and OTC smoking cessation drugs (up to 60-day supply) may be cost shared in mail order ($0 copay) when designated by the Assistant Secretary of Defense, Health Affairs
8. Copayments remain the same as the 2017 rates for dependent survivors of Active Duty Service Members and medically retired service members and their dependents.
General Benefit Design
| Benefit Area | Program Details |
| DAYS SUPPLY LIMIT | RETAIL: Up to 90 days supply (1 copay per 30 days)* |
| Products packaged for greater than 30 day supply: | |
| 1. If the package contains a single dose (i.e., one injection) which has a duration of greater than 30 days, 1 copay will be applied. | |
| 2. If the package contains multiple dosings (i.e. 91 tablets) which together have a duration of greater than 30 days, then 1 copay applies for each 30 days of duration up to 3 copays. |
MAIL ORDER: Up to 90 days per copay*
MTF and MHS GENESIS: Up to 365 days supply for non controlled substances; 180 days for controlled substances as allowed under federal law.
* Day supply limits apply to ADSM but copayments do not apply.
| UNIFORM FORMULARY | TRICARE Uniform Formulary can be found a the following link: |
| http://www.tricare.mil/CoveredServices/Pharmacy/Drugs/NonFormulary |
TIER 4 - Not covered Section 702(b)(10) of the NDAA 2018 was published on December 11, 2018, and is found at: https://www.federalregister.gov/documents/2018/12/11/2018-26562/tricare-pharmacy-benefitsprogram-reforms.
Tier 4 Drug List: <https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Access-to-Healthcare/Pharmacy-Program/TRICARE-Formulary>
MANDATORY GENERIC POLICY
| The following applies to mail/retail, but NOT MHS Genesis |
| *Mandatory generic program but no ancillary charges apply. |
| *DAW1, at mail order will reject: 70 NDC not covered, with message “DAW1-MANDATORY GENERICS” |
| *All other Multi Source brand product claims will reject: 70, NDC Not Covered. |
| Brand over Generic Rule: In certain instances, a brand product may be deemed by the DoD Pharmacy and Therapeutics committee as preferred over the generic and the brand will be allowed to adjudicate. | |
| REFILL TOO SOON OVERRIDES | Refills too Soon logic is set at: |
| 75% for all points of service: Mail, Retail, MHS GENESIS |
66% for medicaitons dispensed at Mail for the Deployment Presciption Program
| Overrides for Refill too soon authroized for: | |
| *Vaction Supply 2X per Year | |
| *Lost or Stolen Medication/Theapy Change | |
| *Deployment / Natural Disaster | |
| *Nursing Home or supply for school | |
| Other Health Insurance (OHI) | Claims with OHI are dependent on pharmacy information on file for OHI |
| 0 = Not specified by patient | |
| 1 = No other coverage | |
| 2 = Other coverage exist - payment collected; to be used when OHI pays toward the total cost of the medication ( Member has double coverage) | |
| 3 = Other coverage billed - claim not covered; to be used when the OHI does not cover the medication due to a benefit exclusion or when a clinjical review is required and denited. Should NOT be used if Primary payer requires a PA but no review has been completed. | |
| 4 = Other coverage exists - payment not collected; to be used when OHI does not make a payment due to this specifi reason | |
| Max Cost per Claim | Max cost per claim reject 78. PBM must validate and apply override |
| *Mail-Order non-compounds at $4,500 | |
| *Retail non-compound at $1,500 | |
| *Compound (retail/mail) at $1,000 | |
| *MHS GENESIS (all claims) at $10,000 | |
| *Certain drugs may be excluded from this edit at specific points of service | |
| PRIOR AUTHORIZATION and MEDICAL NECCESITY FOLLOWS GROUP | Existing prior authorizations or medical neccesity which are active will apply to the member as long as they maintain eligiblity for TRICARE Pharmacy benefit. |
| Example: Active Duty Service Member moves to Retiree status. | |
| ENHANCED USE OF MTFs/TMOP PROGRAM | |
| National Defense Authorization Act (NDAA) for FY 2015, Section 702(c) |
Nonformulary medications are generally restricted to the mail order program according to amended section 199.21, revised paragraphs (h)(3)(i) and (ii), effective August 26, 2015.
TRICARE Policy Manual Chapter 8 Section 9.1, 2.2.12 *The Expanded MTF/Mail Pharmacy Initiative (EMMPI) medication program drug list is defined by the P&T Committee, which recommends additions and removals.
*For additional information on these two programs, refer to the August 2015 DoD P&T Committee meeting minutes, available at http://www.heallh.mil/PandT.
*100% Copayment if obtained in retail POS after 2 courtesy fills of 30 days each.
*The requirement can be waived based on individual patient needs and other appropriate circumstances.
NON-FCP; RETAIL EXCLUSIONS (703b)
NDAA 2010 Sec 703b * Manufactures non-compliant with Sec 703b regulation
* Drug are rejected for PA (by NDC) at the Retail point of service.
* PA available for emergent need or circustances requiring access at Retail
* Drugs move to Non-Formulary (Tier 3) status at Mail (no option for medical neccessity review)
* Does not impact MTF since Tier 3 drugs are generally not avaliable at these point of service Home Infusion Therapy
TRICARE Policy Manual, Ch 8, Sec 20.1 and 9.1
* No defined drug list. Providers determine which drugs are appropriate for this program
* Pharmacy Contractor apply pre-authorization to allow injectable drugs coverage through the pharmacy benefit once approval provided by MCSC.
http://www.tricare.mil/CoveredServices/Pharmacy/Drugs/NonFormulary Drugs Coverage Rules subject to change based on recent decsions from the DoD P&T process.
Most current decisions are available at: <https://health.mil/About-MHS/OASDHA/Defense-Health-Agency/Operations/Pharmacy-Division/DoD-Pharmacy-and-Therapeutics-Committee/Meeting-Minutes>
| Benefit Area | Specific | Covered (Yes) | Covered (No) | Prior Auth / MN** | NOTES | Provide List | List Name |
| COSMETIC PRODUCTS/ INDICATIONS | Photo-aged skin products: (ex. Renova, Avage) | No | *Not covered at MHS Genesis: override ability in place | ||||
| TRICARE Policy Manual 6010.57-M Chapter 4 Section 2.1. Exclusions. Chemical Peeling (exfoliation) for the following: (a) Treatment or removal of facial wrinkles (b) Treatment of acne or acne scars. (c) Treatment of aging skin | Hair growth or depilatory agents (ex. Propecia, Latisse, Vaniqa) | No | *Not covered at MHS Genesis: override ability in place | ||||
| TRICARE Policy Manual 6010.57-M Chapter 4 Section 2.1 Exclusions. Any procedure performed for personal reasons to improve the appearance of an obvious feature or part of the body that would be considered by an average observer to be normal and acceptable for the patient’s age or ethnic or racial background. | |||||||
| TRICARE Policy Manual 6010.57-M Chapter 1 Section 1.2. Exclusions. Services and supplies in connection with cosmetic, reconstructive, or plastic surgery except as specifically provided in 32 CFR 199.4 (e)(8). |
32 CFR 199.4 (g)(24) Exclusions. Cosmetic, reconstructive, or plastic surgery. Services and supplies in connection with cosmetic, reconstructive, or plastic surgery except as specifically provided in paragraph (e)(8) of this section.
Hair growth:
TRICARE Policy Manual 6010.57-M Chapter 8 Section 12.1 Exclusions. Any diagnostic or therapeutic method or supply intended to encourage hair re-growth.
| 32 CFR 199.4 (g)(41)(ii)(D) Exclusions. Any diagnostic or therapeutic method or supply intended to encourage hair re-growth. | Injectable cosmetics: | |||||
| (ex. Botox cosmetic) | No | *Not covered at MHS Genesis: override ability in place | ||||
| DERMATOLOGY | ||||||
| *Policy citations same as above for cosmetic. | Depigmentation products used for skin conditions requiring a bleaching agent | No | *Not covered at MHS Genesis: override ability in place | |||
| CONTRACEPTION | Non-injectable monthly: (ex. oral, Ortho Evra, NuvaRing) | Yes | At retail, participant may receive up to 3 packages at a time for 1 copayment per package. | |||
| When Non-Injectable Monthly products are dispensed at Mail Order and the days supply is 90, the maximum dispensed is 3 packages for one Mail Order copay. |
When the following products are Not Covered implement the standard defaults to allow overrides to adjudicate correctly.
Non-injectable monthly:
1 package at Retail 3 packages at Mail Order
| Non-injectable – 91 day supply only: (ex. Seasonale) | Yes | |
| Injectable-90 day supply only: (ex. Depo-Provera, Depo-SubQ Provera) | Yes |
Injectable-30 days supply Yes
| Implants (ex. Implanon INJ) | ||
| No* | *Covered at MHS Genesis |
| Diaphragms | Yes* | *Retail and MHS Genesis only | |
| IUDs | |||
| No* | |||
| *Covered at MHS Genesis |
Emergency – ALL (e.g Plan B One Step) Yes* *Plan B One Step and its generics are covered for all ages of females at Retail and MTF for $0 copay. No prescription is needed. The pharmacist can submit a claim to TRICARE.
All other Rx EC products covered for females aged 16 years and younger with prescription, OTC and not covered for age 17 and older.
Not available at MOP.
QLL = 1 tablet per dispensing
FERTILITY AGENTS Oral/Vaginal
(ex. Clomid, Crinone)
| Yes | Y | PA_ST_QL_NoPA | ||
| Injectable (ex. Profasi, HCG) | Yes | Only injectable gonadotropins require PA. |
Others are covered without Subject to quantity limits referenced in DoD Formulary Limits and Restrictions Approved PA's only good for 1 yr
| ERECTILE DYSFUNCTION | Non-Injectable | ||
| (ex. Viagra, Levitra, Cialis, Muse) | Yes | PA req for Viagra/Levitra/Cialis/Staxyn for men under 40 |
| PA req for Viagra/Levitra/Cialis/Staxyn for women of any age. | Muse is covered wo/PA | Y | PA_ST_QL_NoPA | |
| TRICARE Policy Manual 6010.57-M Chapter 4 Section 15.1 and Chapter 8 Section 9. | ||||
| Qty/Days : | ||||
| *QLL= 6 tabs-pellets/30 ds and 18 tabs- pellets/90 ds |
**QLL is collective across all oral products.
***QLL applies to Cialis 2.5mg and 5 mg as well
| Injectable | ||||||||
| (ex. Caverject, Edex) | Yes | *QLL= 6 inj/30 ds and 18 inj/90 ds | ||||||
| Medications not FDA approved for Erectile Dsyfunction (ex. Yohimbine) | No | |||||||
| WEIGHT MANAGEMENT | Agents used to suppress appetite and control fat absorption. | |||||||
| (ex. Xenical, Belviq, Qsymia) | Yes | PA req | Y | PA_ST_QL_NoPA | ||||
| An Interim Final Rule published on September 29, 2017, (DOD-2017-HA-RIN 0720) “authorizes coverage under TRICARE Prime and TRICARE Select for medically necessary treatment of obesity, even if it is the sole or major condition treated.” | ||||||||
| ALLERGY TESTING and TREATMENT | FDA approved antigen therapy (ex. Grastek, Ragwitek) | Yes | Unproven allergy treatments and testing are excluded | |||||
| TRICARE Policy Manual 6010.57-M Chapter 7 Section 14.1 Allergy testing and treatment. | ||||||||
| INJECTABLES | Self Administered Injections Only | Yes | The Self-administered Injectable Drug List is comprised of injectable medications deemed safe and appropriate by the manufacturer for self-administration. This list is developed and maintained by the contractor. The initial list and any changes are subject to approval by the government. Injectable medications not considered self-administered are eligible for coverage if deemed medically necessary through a review process established by MCSC. | Y | Self-Admin Injectables -10052019 | |||
| (Other than Insulin or if an Injectable is addressed in any other category within this document) |
32 CFR 199.4 (d)(3)(vi)(A) Prescription Drugs and Medicines. Drugs administered by a physician or other authorized individual professional provider as an integral part of a procedure covered under paragraph (b) or (c) of this section (such as chemotherapy) are not covered under this subparagraph inasmuch as the benefit for the institutional services or the professional services in connection with the procedure itself also includes the drug used.
TRICARE Policy Manual 6010.57-M Chapter 8 Section 9.1 Other Pharmaceutical Delivery Venues. (1.4) Pharmaceutical agents provided by physicians and other appropriate clinicians, and pharmaceutical agents provided in support of home health care are processed by the Managed Care Support Contractor(s) (MCSC). Claims for pharmaceutical agents (e.g., injectables) not appropriate for self-administration are the responsibility of the MCSC. (1.5) When injectable and infusion drug therapy are medically necessary, and delivery and administration in the home is appropriate the MCSC shall provide prior authorization of injectable or infused drugs to a TRICARE authorized pharmacy in order for the pharmaceutical agent to be fulfilled under the pharmacy benefit pursuant to Section 20.1, “Infusion Drug Therapy Delivered in the home”
Allergens No* *Covered at MHS Genesis
Products for Hemophilia Yes Covered at all POS
| Other (Home Infusion Therapy) | No* | *These agents require preauthorization from the Managed Care Support Contractor in order to process though purchased care. See TPM Ch 8 Sec 20.1 Infusion Drug Therapy Delivered In The Home, and MEDICATIONS COVERED UNDER THE TRICARE INFUSION DRUG THERAPY IN THE HOME | ||
| ALL INJECTABLES - no limits | No* | *All injectables are covered under MHS Genesis | ||
| IMPLANTS | E.G Iluvein; Testopel, etc.] | . | No* | *Covered at MHS Genesis |
VACCINES Special List Yes All vaccines are only covered at Retail and MHS Genesis
* Flu Vaccine(only allow coverage for current years) *CDC reference and guidelines y Retail_Vaccine Listing_Sept 2019
VACCINES: Special products Typhim VI Vivotif Berna Imovax Rabies Ixiaro
YF-VAX
Rabavert Rabies Biothrax No* *Only covered at MHS Genesis with no restrictions
| SERUMS & TOXOIDS: | ||||||
| (all dosage forms including Injectable) | ALL | No | ||||
| LEGEND VITAMINS (Oral Only) | Prenatal agents used in pregnancy | Yes | Yes* | *Age Limit PA for women over 45. Women of all other ages covered. | Refer to P&T Minutes | |
| TRICARE Policy Manual 6010.57-M Chapter 8 Section 9.1. Vitamins may be cost-shared only when used as a specific treatment of a medical condition. |
TRICARE Policy Manual 6010.57-M Chapter 8 Section 7.1 Exclusions. Vitamins or mineral preparations, except as provided in POLICY above or by Chapter 8 Section 9.1.
TRICARE Policy Manual 6010.57-M Chapter 1 Section 1.2 Exclusions. Food, food substitutes, vitamins, or other nutritional supplements, including those related to prenatal care, except as specifically covered (see chapter 8, Sections 7.1 and 7.2) 32 CFR 199.4 (g)(57) Exclusions. Food, food substitutes, vitamins, or other nutritional supplements, including those related to prenatal care.
Therapeutic agents used for specific deficiencies and conditions (ex. Rocaltrol, Calcitriol, Niacin, Potaba) Yes Legend products only covered
Legend Multivitamins (usually have OTC counterparts)
(ex. Nephrocaps, Vitacon Forte, Berocca) Yes Legend products only covered
Supplemental agents (usually have OTC counterparts) Ex. Biotin Yes Legend products only covered
Hemopoetic agents used to treat anemia (ex. Folic Acid, Niferex Forte) Yes Legend products only covered
OTC VITAMINS ALL No* *Select OTC vitamins are covered at MHS Genesis and Retail/Mail y MHS Genesis OTCs
| LEGEND FLUORIDE PRODUCTS | Dental (ex. Paste, gel, mouthwash) | No* | *Select products allowed at MHS Genesis | y | Fluoride Productus | |||
| TRICARE Policy Manual 6010.57-M Chapter 8 Section 13.1 (III)(A) Policy Considerations. Dental care which is routine, preventative, restorative, prosthodontic (adding or modifying of bridge work and dentures), periodontic or emergency does not qualify as adjunctive dental care except when performed in preparation for, or as a result of, dental trauma caused by medically necessary treatment of an injury or disease. | ||||||||
| 32 CFR 199.4 (E)(10)(i) Adjunctive dental care: Limited. Adjunctive dental care is limited to those services and supplies provided under the following conditions: (A) Dental care which is medically necessary in the treatment of an otherwise covered medical (not dental) condition, is an integral part of the treatment of such medical condition, and is essential to the control of the primary medical condition. | Pediatric (ex. Luride, Poly-Vi-Flor) | No* | *Select products allowed at MHS Genesis |
LEGEND and OTC SMOKING CESSATION PRODUCTS Varenicline (Chantix) Bupropion SR (Zyban) Nicotine nasal spray (Nicotrol NS) Nicotine inhalation system (Nicotrol) Nicotine transdermal systems (Nicoderm CQ or equivalent products) Nicotine gum (Nicorette or equivalent products) Nicotine lozenges (Nicorette or equivalent products) Yes* *Specific smoking cessation products are covered at mail order only with $0 copay for non-Medicare eligible patients over age 17.
Limited to two 120 day quit attempts per 365 calendar days; 3rd attempt allowed with Prior Authorization. QLL applies.
*MOP replenishment provided with TAA compliant products.
No drug restrictions for MHS Genesis
*See Smoking Cessation drug list for applicable NDC’s.
32 CFR 199.4 (e) (30). The TRICARE smoking cessation program is a behavioral modification program to assist eligible beneficiaries who desire to quit smoking. The program consists of a pharmaceutical benefit; smoking cessation counseling; access to a toll-free quit line for non-medical assistance; and, access to print and internet web-based tobacco cessation materials.
32 CFR 199.21 (a) (2) (ii). The pharmaceutical benefit under the TRICARE smoking cessation program under § 199.4(e)(30) is available to TRICARE beneficiaries who are not entitled to Medicare benefits authorized under Title XVIII of the Social Security Act.
| COMPOUNDED PRODUCTS | Compounds | Yes* |
| MTF/CHDR/TMDS claims are not subject to compound edits |
| OTC MEDICATIONS (other than vitamins – see above) | Purchased Care: Mail & Retail | Yes* | *Covered oral OTC’s at mail/retail: | Y | Covered OTCs -Purchase Care |
| *Only P&T approved OTC’s are covered and process for a generic copay at mail and retail. See NDC Listing for specific products. Plan B One Step OTC and its generics are the only exception as they will continue to process for a $0 copay at retail. |
TRICARE Policy Manual 6010.57-M Chapter 8 Section 9.1. Exclusions. Drugs, including compounded preparations, that are available over the counter.
TRICARE Policy Manual 6010.57-M chapter 8 Section 9.1 (II)(A) Paragraph 2. The prescription drug benefit under TRICARE provides cost sharing for drugs and medicines that (1) are approved for marketing by the U.S. Food and Drug Administration (FDA), and (2) by United States law require a physician’s or other authorized individual professional provider prescription (acting within the scope of their license), and (3) are actually ordered or prescribed by an authorized provider in accordance with state and federal law. The benefit does not include prescription drugs for medical conditions that are expressly excluded form the TRICARE benefit by statute or regulation. The Pharmacy Benefits Program will include a Uniform Formulary of pharmaceutical agents that will assure the availability of pharmaceutical agents in the complete range of therapeutic classes authorized under the TRICARE prescription drug benefit.
32 CFR 199.4 (d)(3)(vi)(A). Other covered services and supplies: Prescription Drugs and Medicines. Prescription drugs and medicines that by United States Law require a physician’s or other authorized individual professional provider’s prescription (acting within the scope of their license) and that are ordered or prescribed by a physician or other authorized individual professional provider (except that insulin is covered for a known diabetic, even though a prescription may not be required for its purchase) in connection with an otherwise covered condition or treatment, including Rh immune globulin. MHS Genesis Yes** **P&T will make updates to the list Y MHS Genesis OTCs
| DIABETIC SUPPLIES | Syringes, Needles, Insulin Pump Tubing and Insulin Pump Reservoir or Cartridges. | Yes | *QLL applies to syringes/needles for all POS: mail/retail/MHS Genesis | Y | PA_ST_QL_NoPA | ||
| Insulin Pump | No* | *Covered at MHS Genesis | |||||
| Non pre-filled insulin injection devices (ex. Insulin pen devices) | No* | *Covered at MHS Genesis | |||||
| Swabs | No* | *Covered at MHS Genesis | |||||
| Blood Monitors and Kits | No* | *Covered at MHS Genesis | |||||
| Blood Test Strips (Glucose or Ketone) | Yes | *PA and QLL applies for all POS: mail/retail/MHS Genesis | |||||
| Blood Glucose Calibration Solutions | No* | *Covered at MHS Genesis | |||||
| Continous glucose monitoring devices and supplies (Dexcom, Eversense, etc) | No | ||||||
| Urine Tests | Yes | ||||||
| Lancets | Yes | *QLL applies | |||||
| Lancet Devices | No* | *Covered at MHS Genesis | |||||
| Other – External pumps like Omnipod; T-SLIM | No* | *Covered at MHS Genesis | |||||
| Other: V-Go SQ insulin device | Yes | Yes | PA required/ Also has a QLL | ||||
| DURABLE MEDICAL EQUIPMENT | Catheters and Cannulas | No | |||||
| Respiratory Spacers for oral inhalers. | Yes | ||||||
| Peak Flow Meters | No | ||||||
| Respiratory supplies such as nebulizers and respiratory mask | No | ||||||
| Ostomy Supplies | No | ||||||
| Non-Insulin Syringes | Yes | ||||||
| LEGEND DIAGNOSTIC/TESTING/ IMAGING SUPPLIES | ALL (ex. Tubersol used for TB skin test, Radiopaque dye for outpatient testing) | No* | *Covered at MHS Genesis | ||||
| LEGEND HOMEOPATHIC DRUGS (all dose forms) | Example: Arnica; Rhus Tox, etc. | No | |||||
| TRICARE Policy Manual 6010.57-M Chapter 8 Section 9.1. General Prescription Coverage. Labeled Indications. Drugs may be cost shared when: The drug is approved for marketing by the U.S. Food and Drug Administration; |
TRICARE Policy Manual 6010.57-M chapter 1 Section 2.1. Any drug, device, medical treatment, or procedure whose safety and efficacy has not been established is unproven and excluded from coverage.
32 CFR 199.4 (d)(3)(vi)(B). CHAMPUS benefits may not be extended for drugs not approved by the U.S. Food and Drug Administration for commercial marketing. Drugs grandfathered by the Federal Food, Drug and Cosmetic Act of 1938 may be covered under CHAMPUS as if FDA approved.
32 CFR 199.4 (e)(15). Unproven drugs, devices and medical treatments or procedures. By law, CHAMPUS can only cost share medically necessary supplies and services. Any drug, device, or medical treatment or procedure, the safety and efficacy of which have not been established, as described in this paragraph (g)(15), is unproved and cannot be cost shared by CHAMPUS.
32 CFR 199.4 (e)(15)(i)(A). A drug, device, or medical treatment or procedure is unproven: if the drug or device cannot be lawfully marketed without the approval or clearance of the United States Food and Drug Administration (FDA) and approval or clearance for marketing has not been given at the time the drug or device is furnished to the patient
LEGEND MEDICAL FOOD Example: Neophe Tablet , Deplin Tablet Zycose Tablet No* *Medical foods are only covered if they are dual classified as a legend vitamin as well (2009 implementation).
*Not covered at MHS Genesis: override ability in place Y MHS Genesis OTCs
| TRICARE Policy Manual 6010.57-M Chapter 1 Section 1.1 (I)(57) Exclusions. Food, food substitutes, vitamins, or other nutritional supplements, including those related to prenatal care, except as specifically covered (see chapter 8, Sections 7.1 and 7.2)32 CFR 199.4 (g)(57) Exclusions. Food, food substitutes, vitamins, or other nutritional supplements, including those related to prenatal care. | |||||||
| MEDICATIONS REQUIRING SPECIALTY SERVICES | Special List | Yes | See attached list, prior authorizations and quantity limits may apply | y | DRAFT | ||
| MEDICATIONS REQUIRING PRIOR AUTHORIZATION DETERMINATION | Special List | Yes | See attached list DoD Formulary Restrictions and Limitations, quantity limits may also apply | y | PA_ST_QL_NoPA | ||
| MEDICATIONS REQUIRING MEDICAL NECESSITY DETERMINATION | Special List | Yes | See attached list DoD Formulary Restrictions and Limitations, quantity limits may also apply | y | Non-Formulary NDCs_10052019 | ||
| MEDICATIONS SUBJECT TO STEP THERAPY | Special List | Yes | See Attached List | ||||
| y | PA_ST_QL_NoPA | ||||||
| MEDICATIONS WITH SPECIFIC QUANTITY LIMITS | Special List | Yes | See attached list | ||||
| Overrides are available | y | PA_ST_QL_NoPA | |||||
| MEDICATIONS WITH AGE/ GENDER LIMITS | Special List | Yes | See attached list | y | PA_ST_QL_NoPA | ||
| MEDICATIONS COVERED UNDER THE TRICARE INFUSION DRUG THERAPY IN THE HOME (HOME INFUSION THERAPY PROGRAM (HIT)) | No Standard drug lists across MCSC's | Yes- Contractor enters override based on authorization from the MCSC | See TPM, Section 20.1, Chapter 8 |
DOES NOT APPLY to MHS Genesis
NON-FCP, RETAIL EXCLUSION, NDAA 2010; Section 703b Special List Yes - Retail Only Government Directed List - NDC level Drugs are NF at MOP (MN does not apply) Drugs reject at Retail without an approved PA.
| DOES NOT APPLY to MHS Genesis | y | non-FCP 703b NDCs_10052019 | ||
| BRAND PREFERRED OVER GENERIC | Lialda | Yes | *The brand pays at a UF co-pay while the generic rejects for "PA required" with messaging back to the pharmacy identifying the brand as preferred |
*Drug list is managed by the DoD P&T (currently only one drug identified) DOES NOT APPLY to MHS Genesis
| NEUTRACEUTICALS | E.G - Resveratrol; Probiotics) | No | No overrides available | |
| Enhanced USE OF MTF or MHS Genesis/TMOP PROGRAM | ||||
| (See also in General design tab) | Retail to Mail and MTF conversion | Yes | Waivers available |
*Maintenance meds only *Govt maintained list *2 courtesy fills at retail; waivers available *DOES NOT APPLY to MHS Genesis
| y | EMM_10052019 | |
| Tier 4 - Not Covered Drugs | ||
| Section 702(b)(10) of the NDAA 2018 | Glumetza (and generics) |
Vimovo Lexette No No PA *Appeals accepted for coverage determination Drug List <https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Access-to-Healthcare/Pharmacy-Program/TRICARE-Formulary>
File details come from the government source that posted it. Updated .